Concepedia

Publication | Open Access

Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy

DOIFull Paper Access

536

Citations

24

References

2006

Year

Dan Ziegler, P. James B. Dyck, Irina Gurieva, Phillip A. Low, Ullrich Munzel, N. N. Yakhno, Itamar Raz, Maria Novosadova, Joachim Maus
Diabetes Care

Abstract

Oral treatment with ALA for 5 weeks improved neuropathic symptoms and deficits in patients with DSP. An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.

References

YearCitations

Page 1